Adam Kaplin
Director/Board Member bei Cody Unser First Step Foundation
Vermögen: 220 000 $ am 31.03.2024
Profil
Adam Kaplin is the founder of MIRA Pharmaceuticals, Inc., which was founded in 2020.
He held the title of President & Chief Science Officer from 2022 to 2024.
Dr. Kaplin is also currently working at The Johns Hopkins University as the Director of the Johns Hopkins Ketamine Clinic since 2002.
Additionally, he is the Director of Cody Unser First Step Foundation since 2005.
Previously, Dr. Kaplin worked as the Chief Scientific Officer at MyMD Pharmaceuticals, Inc. from 2020 to 2024.
Dr. Kaplin obtained his doctorate degree from The Johns Hopkins University in 1996 and his undergraduate degree from Yale University in 1988.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
03.08.2023 | 200 000 ( 1,35% ) | 220 000 $ | 31.03.2024 | |
29.03.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Adam Kaplin
Unternehmen | Position | Beginn |
---|---|---|
The Johns Hopkins University | Corporate Officer/Principal | 01.01.2002 |
Cody Unser First Step Foundation | Director/Board Member | 01.01.2005 |
Ehemalige bekannte Positionen von Adam Kaplin
Unternehmen | Position | Ende |
---|---|---|
MYMD PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 15.04.2024 |
MIRA PHARMACEUTICALS, INC. | Founder | 07.03.2024 |
Ausbildung von Adam Kaplin
The Johns Hopkins University | Doctorate Degree |
Yale University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
MYMD PHARMACEUTICALS, INC. | Health Technology |
MIRA PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Cody Unser First Step Foundation |